Results 11 to 20 of about 151,327 (305)

Gastroenteropancreatic Neuroendocrine Tumors [PDF]

open access: yesCA: A Cancer Journal for Clinicians, 2018
Abstract Neuroendocrine tumors (NETs) are heterogeneous malignancies arising from the diffuse neuroendocrine system. They frequently originate in the gastroenteropancreatic (GEP) tract and the bronchopulmonary tree, and their incidence has steadily increased in the last 3 decades.
Cives, Mauro, Strosberg, Jonathan R
openaire   +5 more sources

The influence of surgery quality on the longtime results of gastric cancer combination therapy

open access: yesNowotwory, 2022
INTRODUCTION: The aim of this study was to analyze the influence of surgical center experience on the long term survival of patients with locoregionally advanced gastric adenocarcinoma undergoing primary surgery, followed by comple­mentary ...
Ireneusz Pierzankowski   +4 more
doaj   +1 more source

Risk of malignancy in adrenal tumors in patients with a history of cancer

open access: yesFrontiers in Oncology, 2023
PurposeAdrenal gland is a common site of metastasis and on the other hand, metastases are the most frequent malignant adrenal tumors. The aim of this study was to estimate the risk of malignancy in suspicious adrenal mass in patients with a history of ...
Radosław Samsel   +11 more
doaj   +1 more source

Updates on medical treatment for neuroendocrine neoplasm [PDF]

open access: yesZhongguo aizheng zazhi, 2022
Neuroendocrine neoplasm (NEN) is a group of heterogeneous malignancies arising from neuroendocrine cells and peptidergic neurons. According to its cell differentiation, NEN can be divided into two distinct groups as well-differentiated neuroendocrine ...
LIANG Yun, JI Shunrong, YU Xianjun, CHEN Jie
doaj   +1 more source

Achieving objective response in treatment of non-resectable neuroendocrine tumors does not predict longer time to progression compared to achieving stable disease

open access: yesBMC Cancer, 2020
Background There are several treatment modalities for unresectable neuroendocrine tumors. Traditionally, the aim of these treatments has been to reduce the tumor load; referred to as objective response (OR).
Espen Thiis-Evensen   +3 more
doaj   +1 more source

Updates on precision medicine of pancreatic neuroendocrine tumor [PDF]

open access: yesZhongguo aizheng zazhi, 2023
Since the concept of precision medicine proposed in 2011, the treatment of solid tumors has entered era of precision medicine led by gene testing. As a rare tumor, the incidence rate of pancreatic neuroendocrine tumor (PanNET) is increasing gradually. In
GAO Heli, XU Jin, CHEN Jie, YU Xianjun
doaj   +1 more source

Synaptophysin-Ki67 double stain: a novel technique that improves interobserver agreement in the grading of well-differentiated gastrointestinal neuroendocrine tumors. [PDF]

open access: yes, 2017
A common problem in the assessment of Ki67 proliferative index in well-differentiated gastrointestinal neuroendocrine tumors is distinguishing tumor from non-tumor.
Beckett, Laurel   +5 more
core   +1 more source

A real-life treatment cohort of pancreatic neuroendocrine tumors: High-grade increase in metastases confers poor survival

open access: yesFrontiers in Endocrinology, 2022
BackgroundTumor grade determined by the Ki67 index is the best prognostic factor for pancreatic neuroendocrine tumors (PanNETs). However, we often observe that the grade of metastases differs from that of their primary tumors.
Wu-Hu Zhang   +60 more
doaj   +1 more source

Fine needle aspiration cytology of hepatic metastases of neuroendocrine tumors: A 20‐year retrospective, single institutional study [PDF]

open access: yes, 2017
Background Fine needle aspiration (FNA) is considered an excellent technique for documenting metastatic neuroendocrine tumors (NETs). This study aims to evaluate the accuracy of FNA in diagnosing metastatic NETs to the liver and determining the grade ...
Cramer, Harvey   +3 more
core   +1 more source

Carcinoid Syndrome and Hyperinsulinemic Hypoglycemia Associated with Neuroendocrine Neoplasms: A Critical Review on Clinical and Pharmacological Management

open access: yesPharmaceuticals, 2021
The carcinoid syndrome (CS) and hyperinsulinemic hypoglycemia (HH) represent two of the most common clinical syndromes associated with neuroendocrine neoplasms (NENs).
Francesca Spada   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy